Pharmaceutical

Filter

Current filters:

None

Popular Filters

6801 to 6825 of 6942 results

BMI ups forecast for Swedish pharmaceuticals market

16-08-2011

While Sweden boasts one of the most admirable economies in the world, its pharmaceutical market is not…

EuropeMarkets & MarketingPharmaceutical

Pfizer wins case to stop Teva selling generic Viagra in USA

16-08-2011

Global pharmaceutical behemoth Pfizer (NYSE: PFE) revealed yesterday that it has prevailed in its patent…

GenericsLegalNorth AmericaPatentsPfizerPharmaceuticalReproductiveTeva Pharmaceutical IndustriesViagra

Gilead’s investigational Quad HIV regimen meets primary endpoint in Pivotal Ph III study

16-08-2011

US biotech Gilead Sciences (Nasdaq: GILD) yesterday announced positive results from a Phase III clinical…

Anti-viralsBiotechnologyGilead SciencesPharmaceuticalResearch

Positive top-line Ph III results of Impax and GSK IPX066 in advanced Parkinson’s disease

16-08-2011

USA-based Impax Pharmaceuticals, the branded products division of Impax Laboratories, (Nasdaq: IPXL),…

GlaxoSmithKlineImpax LaboratoriesNeurologicalPharmaceuticalResearch

Pharming extends Ruconest deal with SOBI

16-08-2011

Netherlands-based biotech firm Pharming Group NV (Euronext: PHARM) has extended its existing agreement…

BiotechnologyEuropeLicensingPharmaceuticalPharmingRare diseasesRest of the WorldRhucinRuconestSwedish Orphan Biovitrum

Chugai gets rights to Roche melanoma drug vemurafenib in Japan

15-08-2011

Japanese drugmaker Chugai Pharmaceutical (TYO: 4519) said yesterday that it has entered into a license…

Chugai PharmaceuticalLicensingOncologyPharmaceuticalRochevemurafenib

Pulmatrix to focus on COPD and cystic fibrosis clinical programs

15-08-2011

US drug developer Pulmatrix say that its clinical development plans will focus on the company’s…

FinancialPharmaceuticalPulmatrixResearchRespiratory and Pulmonary

Bayer makes moxifloxacin available to help WHO TB program in China

15-08-2011

Bayer HealthCare, a unit of Germany’s Bayer AG (BAY: DE), has agreed to support the World Health…

Antibiotics and Infectious diseasesAsia-PacificBayerMarkets & MarketingMoxifloxacinPharmaceutical

US FDA signs deal to advance regulatory science with Arkansas state

15-08-2011

An agreement to establish a virtual Center of Excellence for Regulatory Science was signed last week…

BiotechnologyNorth AmericaPharmaceuticalRegulationResearch

Pharma contract manufacturing revenues to reach $64.07 billion in 2016, says Visiongain

15-08-2011

The global contract manufacturing sector will generate revenues of $64.07 billion in 2016, according…

GenericsGlobalMarkets & MarketingPharmaceutical

South Korea to cut pharma prices by average 17% to save $1.94 billion

15-08-2011

In a move that is likely to curb current growth prospects for the pharmaceutical industry in South Korea,…

Asia-PacificGenericsPharmaceuticalPricing

Novartis' imatinib patent battle resumes in Indian Supreme Court

15-08-2011

The controversial Novartis case in which the Swiss major Novartis (NOVN: VX) challenged the manner in…

Asia-PacificGleevecGlivecNovartisOncologyPatentsPharmaceutical

Shionogi completes new $247 million research facility

15-08-2011

Japanese drug major Shionogi (TKO: 4507)last week held an inauguration ceremony of the new pharmaceutical…

FinancialPharmaceuticalResearchShionogi

USA has one of least cost-effective health care systems in world, according to new study

14-08-2011

The USA has finished near the bottom of a study conducted that sought to compare how its health care…

HealthcarePharmaceutical

Sub-Saharan group says legal and policy barriers to HIV should be confronted

14-08-2011

In Sub-Saharan Africa, the region most heavily affected by HIV, legal, policy and social barriers, including…

Anti-viralsLegalPharmaceuticalPoliticsRest of the World

Oral anti-diabetic drug adherence among Medicare Part D beneficiaries improved by mail services; study

14-08-2011

Findings from a new study published on-line in the Journal of Medical Economics suggest that, in the…

DiabetesMarkets & MarketingNorth AmericaPharmaceutical

US life sciences VC deals up in value but down 9% in volume

14-08-2011

Venture capitalists in the USA invested $5.9 billion in 736 deals in the first quarter of 2011, according…

BiotechnologyFinancialNorth AmericaPharmaceutical

Teijin and Astellas expand collaboration on gout drug febuxostat

12-08-2011

Japanese drugmakers Teijin Pharma (TYO: 3401 and Astellas Pharma (TKO:4503) have entered into an exclusive…

Anti-Arthritics/RheumaticsAsia-PacificAstellas PharmafebuxostatLicensingPharmaceuticalTeijin

NEJM report confirms Xarelto as safe and effective as warfarin, says Bayer

12-08-2011

Data newly-published in the New England Journal of Medicine (NEJM) demonstrate that German drug major…

BayerCardio-vascularJohnson & JohnsonPharmaceuticalResearchXarelto

Good first-half results from Stada Arz driven by branded and generic drugs

11-08-2011

German drugmaker Stada Arzneimittel reported first-half 2011 results with 7% growth in group sales to…

FinancialGenericsPharmaceuticalSTADA Arzneimittel

Broker reviews Paion, beyond the stroke delay by partner Lundbeck

11-08-2011

Citing slow recruitment into its two Phase III studies, German biopharmaceutical company Paion’s…

desmoteplaseFinancialLundbeckNeurologicalPaionPharmaceuticalRegulationremimazolam

6801 to 6825 of 6942 results

Back to top